Skip to main content
A cell–ECM screening method to predict breast cancer metastasis
Integrative Biology
  • Lauren E. Barney, University of Massachusetts Amherst
  • E. C. Dandley, North Carolina State University
  • Lauren Jansen, University of Massachusetts Amherst
  • Nicholas G. Reich, University of Massachusetts Amherst
  • A. M. Mercurio, University of Massachusetts Medical School
  • Shelly Peyton, University of Massachusetts Amherst
Publication Date

Breast cancer preferentially spreads to the bone, brain, liver, and lung. The clinical patterns of this tissue-specific spread (tropism) cannot be explained by blood flow alone, yet our understanding of what mediates tropism to these physically and chemically diverse tissues is limited. While the micro- environment has been recognized as a critical factor in governing metastatic colonization, the role of the extracellular matrix (ECM) in mediating tropism has not been thoroughly explored. We created a simple biomaterial platform with systematic control over the ECM protein density and composition to determine if integrin binding governs how metastatic cells differentiate between secondary tissue sites. Instead of examining individual behaviors, we compiled large patterns of phenotypes associated with adhesion to and migration on these controlled ECMs. In combining this novel analysis with a simple biomaterial platform, we created an in vitro fingerprint that is predictive of in vivo metastasis. This rapid

biomaterial screen also provided information on how b1, a2, and a6 integrins might mediate metastasis in

patients, providing insights beyond a purely genetic analysis. We propose that this approach of screening many cell–ECM interactions, across many different heterogeneous cell lines, is predictive of in vivo behavior, and is much simpler, faster, and more economical than complex 3D environments or mouse models. We also propose that when specifically applied toward the question of tissue tropism in breast

cancer, it can be used to provide insight into certain integrin subunits as therapeutic targets.

This work was funded by an NSF-NCI award DMR-1234852 to SRP and NGR, the University of Massachusetts, Amherst, and by a grant from the NIH (1DP2CA186573-01). SRP is a Pew Biomedical Scholar sup- ported by the Pew Charitable Trusts. LEB was partially supported by National Research Service Award T32 GM008515 from the National Institutes of Health. ECD was partially supported by an HHMI undergraduate research fellowship. AMM was supported by NIH Grant CA168464.
Citation Information
Lauren E. Barney, E. C. Dandley, Lauren Jansen, Nicholas G. Reich, et al.. "A cell–ECM screening method to predict breast cancer metastasis" Integrative Biology Vol. 7 (2015)
Available at: